Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FW5SW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,471
Award facts
- Contract value 100% obligated
- $14,471.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $14,471.36 delivery order to Amerisourcebergen Drug Corp on June 17, 2026, for ondansetron ODT 4 mg tablets (30 count), with ultimate completion on June 18, 2026. The order is issued under a single-award indefinite delivery contract with DLA supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply through December 2036.
Place of performance is Conshohocken, PA. Pricing is firm fixed price, and no set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FW5SW?
SPE2DR26FW5SW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2026.
How much is contract SPE2DR26FW5SW worth?
The government has obligated $14,471 on SPE2DR26FW5SW.
Is contract SPE2DR26FW5SW an order under another contract?
Yes. SPE2DR26FW5SW is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW5SW competed?
The extent of competition for SPE2DR26FW5SW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award